Evidence map›Paper›PMID 41731623›Full record

ArticleNeurological research and practice2026

Evaluation of predictors indicating paroxysmal atrial fibrillation in patients with acute ischemic strokes: the Find-AF

Mark Weber-Krüger, Antonia Zapf, Evgeny Protsenko, Jan Liman, Gerhard F Hamann, Pawel Kermer, Katrin Wasser, Timo Uphaus, Sonja Gröschel, Klaus Gröschel and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Neurological research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01855035 (A Prospective, Randomised, Controlled Study to Determine the Detection of Atrial Fibrillation by Prolonged and Enhanced Holter Monitoring as Compared to Usual Care in Stroke Patients), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01855035 nacompletednot on this map

A Prospective, Randomised, Controlled Study to Determine the Detection of Atrial Fibrillation by Prolonged and Enhanced Holter Monitoring as Compared to Usual Care in Stroke Patients

TypeinterventionalSponsorInstitut fuer anwendungsorientierte Forschung und klinische Studien GmbHRan2013 to 2017Enrolled402ConditionsStrokeArmsprolonged ECG monitoring, standard care
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mark Weber-KrügerClinic for Palliative Care, University Medicine Göttingen, Göttingen, Germany.ORCID http://orcid.org/0009-0008-7052-8755
Antonia ZapfInstitute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Evgeny ProtsenkoClinic for Neurology, Nordwestkrankenhaus Sanderbusch, Sande, Germany.
Jan LimanClinic for Neurology, Klinikum Nürnberg, Nürnberg, Germany.
Gerhard F HamannGerhard F. Hamann, Independent, Wiesbaden, Germany.
Pawel KermerClinic for Neurology, Nordwestkrankenhaus Sanderbusch, Sande, Germany.
Katrin WasserClinic for Neurology, University Medicine Göttingen, Göttingen, Germany.
Timo UphausClinic and Policlinic for Neurology, University Medicine Mainz, Mainz, Germany.
Sonja GröschelClinic and Policlinic for Neurology, University Medicine Mainz, Mainz, Germany.
Klaus Gröschel *Clinic and Policlinic for Neurology, University Medicine Mainz, Mainz, Germany.
Rolf Wachter *Clinic and Policlinic for Cardiology, University Medicine Leipzig, Leipzig, Germany. rolf.wachter@medizin.uni-leipzig.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDetecting concealed paroxysmal atrial fibrillation after stroke requires elaborate electrocardiographic monitoring. We evaluated previously established predictors to quantify the individual risk of detecting atrial fibrillation within six months in the Find-AFRANDOMISED-trial.

methodsWe analyzed 200 patients ≥ 60 years with acute ischemic strokes in the intervention arm of the Find-AFRANDOMISED-trial. Patients received three ten-day Holter-electrocardiograms within six months. Regression analyses and receiver-operator-characteristics were used to select promising biomarkers and assess predictive performance. We applied previously established cut-offs for the most promising markers to determine those at a high risk of underlying atrial fibrillation.

results27/200 patients (13.5%) had atrial fibrillation after six months. The left atrial diameter, atrial premature beats, supraventricular runs and brain natriuretic peptide were associated with atrial fibrillation, whereas the established markers age and suspected stroke etiology were not. Atrial premature beats differentiated best between those with and without atrial fibrillation (area-under-the-curve = 0.75). Only brain natriuretic peptide ≥ 100pg/ml and supraventricular runs ≥ 20 beats independently predicted atrial fibrillation in multivariable models.

conclusionsSupraventricular runs and brain natriuretic peptide were the most promising predictors to define a high risk of underlying atrial fibrillation after stroke in our study. Future screening strategies for atrial fibrillation in stroke patients should focus on these parameters rather than the suspected stroke etiology.

trial registrationclinicaltrials.gov NCT01855035 registered 05132013 https//www.clinicaltrials.gov/study/NCT01855035?tab=table.

Identifiers

PMID41731623
PMCPMC12931031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.